Introduction {#s1}
============

Within the animal kingdom, regenerative capacity of damaged organs and body parts differs widely. While regenerative capacity is generally low in mammalian species, this can be very efficient in specific fish and amphibians ([@bib53]). Even amongst animals of the same species, such as Astyanax mexicanus a teleost fish like the zebrafish, regenerative capacity can vary significantly ([@bib64]). A better understanding of these differences and the cellular and molecular processes during tissue regeneration might ultimately help to improve the regenerative capacity of organs and tissues with poor intrinsic regenerative capacity.

The mammalian adult heart has very little regenerative capacity. The myocardium lost after an injury is replaced by scar tissue, which does not contribute to cardiac contraction resulting in reduced pumping efficiency and ultimately heart failure. Although a low level of cardiomyocyte turnover has been observed, there is no evidence of a stem cell population in the mammalian heart ([@bib35]; [@bib69]). Instead, a rare population of endogenous cardiomyocytes retains the capacity to proliferate to maintain cardiac homeostasis ([@bib2]; [@bib3]; [@bib33]; [@bib60]). Contrary to the adult heart, the neonatal mouse and potentially human heart still have the capacity to regenerate after injury ([@bib25]; [@bib51]). This regenerative capacity of the neonatal heart involves proliferation of pre-existing cardiomyocytes and is lost soon after birth most likely due to a sharp decrease in cardiomyocyte proliferation ([@bib51]; [@bib62]). Recent efforts to enhance proliferation of cardiomyocytes by either inhibiting Hippo signaling or activating the Nrg1/ErbB2 signaling pathway in the adult mammalian heart have been successful and show the potential of existing cardiomyocytes to reenter the cell cycle. ([@bib4]; [@bib11]; [@bib26]).

The zebrafish heart regenerates very efficiently and will regrow cardiac muscle without scarring ([@bib52]). Lineage tracing experiments revealed a model in which proliferation of preexisting cardiomyocytes replaces the myocardium that was lost during the injury ([@bib29]; [@bib32]). While cardiomyocyte proliferation in the uninjured adult zebrafish heart is very low, 3 days after the injury (dpi) cardiomyocytes near the injury area (so-called border zone) start to reenter the cell cycle as observed by the induction PCNA expression, phosphorylated histone three and BrdU incorporation and proliferation peaks at 7 days post injury (dpi) ([@bib29]; [@bib32]; [@bib6]; [@bib20]; [@bib59]; [@bib73]). At the time when proliferation is observed, cardiomyocytes located in the border zone start to express cardiac transcription factors known for their role in embryonic heart development such as *nkx2.5* and *tbx20* and activate *gata4* enhancer elements ([@bib32]; [@bib37]). In addition, border zone cardiomyocytes show signs of dedifferentiation such as disorganization of sarcomere structures and the reexpression of embryonic myosins ([@bib29]; [@bib73]). There is increasing evidence that other (non-muscle) cells in the heart secrete growth factors that stimulate cardiomyocyte proliferation including retinoic acid, TGF-b ligands, insulin-like growth factor, Hedgehog, and Neuregulin ([@bib7]; [@bib9]; [@bib13]; [@bib16]; [@bib37]; [@bib73]; [@bib78]; [@bib77]). In addition to these growth factors, prolonged hypoxia stimulates cardiomyocyte proliferation ([@bib30]; [@bib40]).

The proliferating cardiomyocytes exist within a heterogeneous cell population including non-proliferating cardiomyocytes, endothelial cells and immune cells, hampering the discovery of genetic programs specific for these proliferating cardiomyocytes using whole tissue or spatially resolved RNA-sequencing (RNA-seq) approaches ([@bib31]; [@bib38]; [@bib61]). To identify molecular processes that differ between proliferating and non-proliferating cardiomyocytes, we explored a single-cell RNA-seq approach using the regenerating zebrafish heart. We found that upon injury, adult border zone cardiomyocytes dedifferentiate and resemble embryonic cardiomyocytes on a transcriptomic level. In addition, while adult cardiomyocytes mainly rely on fatty acid metabolism and mitochondrial oxidative phosphorylation (OXPHOS), border zone cardiomyocytes have reduced mitochondrial OXPHOS activity while genes encoding enzymes for glycolysis are induced and glucose uptake is enhanced. Importantly, Nrg1/ErbB2 signaling is sufficient to induce metabolic reprogramming in adult cardiomyocytes of both zebrafish as well as the murine hearts. In addition, the metabolic reprogramming from mitochondrial OXPHOS to glycolysis is required for efficient cardiomyocyte proliferation.

Together, these data support a model in which cardiomyocytes located in the border zone of the regenerating zebrafish heart undergo metabolic reprogramming, which is essential for cardiomyocyte proliferation and that this mechanism is conserved in a murine model with Nrg1/ErbB2 induced regeneration.

Results {#s2}
=======

Single-cell RNA-seq reveals transcriptionally distinct border zone cardiomyocytes {#s2-1}
---------------------------------------------------------------------------------

The border zone comprises only a small fraction of the total number of cardiomyocytes in the injured ventricle ([@bib73]). Several genes and regulatory sequencing have been identified that mark border zone cardiomyocytes, including *nppa*, which encodes for the cardiac stress hormone ANF ([@bib32]; [@bib73]). To mark these borderzone cardiomyocytes we generated a transgenic zebrafish *nppa* reporter line (*TgBAC(nppa:mCitrine)*) in which mCitrine expression recapitulates endogenous cardiac expression of *nppa* ([Figure 1---figure supplement 1a--e](#fig1s1){ref-type="fig"}). While low *nppa:mCitrine* expression was observed in trabecular cardiomyocytes of the remote area, higher expression was detected in the trabecular and cortical cardiomyocytes close to the injured area ([Figure 1a](#fig1){ref-type="fig"} and [Figure 1---figure supplement 1e](#fig1s1){ref-type="fig"}). Moreover, expression of *nppa* correlates with previously reported border zone activity of *gata4* regulatory elements ([Figure 1---figure supplement 1f](#fig1s1){ref-type="fig"}) ([@bib32]). Histochemical analysis of cryo-injured adult hearts revealed that 75% (±7%, n = 3) of the cardiomyocytes expressing high levels of *nppa:mCitrine* reentered the cell cycle ([Figure 1a](#fig1){ref-type="fig"}). To obtain border zone (proliferating) and remote (non-proliferating) cardiomyocytes from the same tissue for further analysis, we cryo-injured *nppa:mCitrine* hearts followed by cell dissociation and FACS sorting for both mCitrine^high^ and mCitrine^low^ cells ([Figure 1b](#fig1){ref-type="fig"}). Individual, living cells were sorted, followed by single-cell mRNA-sequencing using the SORT-seq (SOrting and Robot-assisted Transcriptome SEQuencing) platform ([@bib46]) ([Figure 1---source data 1](#fig1sdata1){ref-type="supplementary-material"}). In total 768 cells where sequenced in which we detected 19257 genes. We detected an average of 10,443 reads per cell and we introduced a cutoff at minimally 3500 reads per cell before further analysis, which resulted in the analysis of 352 cells. To identify the cardiomyocytes amongst the other cell types, we first identified the different cell types based on their transcriptomes. k-medoids clustering of the single cell transcriptomes by the RaceID clustering algorithm was used ([@bib21]) ([Figure 1c](#fig1){ref-type="fig"} and [Figure 1---source data 2](#fig1sdata2){ref-type="supplementary-material"}), and visualized in two dimensions using *t*-distributed stochastic neighbor embedding (*t*-SNE) ([Figure 1d](#fig1){ref-type="fig"}). A total of 12 cell clusters were identified, including a large group of cardiomyocytes (clusters 1,2,4,7 and 9), a smaller group of endothelial cells (clusters 5,6,8,10 and 12), and some fibroblasts (cluster 3) and immune cells (cluster 11) using the expression of marker genes for specific cell types ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). Based on the transcriptome clustering, the cardiomyocytes fell into four main transcriptionally-defined clusters (1, 2, 4 and 7), indicating that the injured heart contained subgroups of cardiomyocytes. To address whether the border zone cardiomyocytes were enriched in one of the four cardiomyocyte clusters we compared the mCitrine fluorescence intensity (recorded during FACS sorting) of the cardiomyocyte and found that the average intensity was highest in cluster 7 and lowest in cluster 2 ([Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}). In addition, we analysed the single-cell transcriptome data for the expression of *nppa* and compared this to the expression of *vmhc* and *mustn1b*, which mark border zone cardiomyocytes, and again found that cells expressing these genes were mostly in cluster 7 ([Figure 1e](#fig1){ref-type="fig"} and [Figure 1---figure supplement 4](#fig1s4){ref-type="fig"}). Together, these results indicate two things: first, the border zone cardiomyocytes (grouped in cluster 7) can be identified as a separate group in the single-cell RNA-seq data. Secondly, these border zone cardiomyocytes are transcriptionally distinct from remote cardiomyocytes (grouped in cluster 2), while two intermediate cardiomyocyte clusters lie in between.

![Single-cell mRNA sequencing identifies different cardiomyocyte-populations in the injured zebrafish heart.\
(**a**) Schematic of cryoinjury procedure on adult TgBAC(*nppa*:mCitrine) fish and immunohistochemistry on section of injured *TgBAC(nppa:mCitrine)* heart 7 dpi. Overview image on left and zoom-in of boxed region on the right. Mef2 (in magenta) labels cardiomyocytes, nppa:mCitrine (in green) marks the borderr zone, and PCNA (in cyan) marks proliferating cells. Arrows indicate triple-positive cells. Dashed line indicates injury site. Scale bar in overview 50 μm. Scale bar in zoom-ins 20 μm. (**b**) Experimental outline of the single-cell mRNA-sequencing of injured zebrafish hearts (blue, injury area; green, border zone) (**c**) Pairwise correlation between individual cells across all genes detected. Color-code indicates cell-to-cell distances measured by \[1 -- Pearson's correlation coefficient\]. StemID clusters are indicated by color and number on the x- and y-axis. (**d**) t-distributed stochastic neighbor embedding (tSNE) map representation of transcriptome similarities between individual cells. (**e**) tSNE maps visualizing log2-transformed read-counts of the border zone marker genes *nppa*, *mustn1b* and *vmhc*.\
Figure 1---source data 1.Single-cell mRNA sequencing data from cryoinjured *TgBAC(nppa:mCitrine)* zebrafish hearts at 7 dpi.Raw reads are represented per gene (rows) and single cell (columns).\
Figure 1---source data 2.List of the clusters in the adult injured heart (raw data see SD1), as identified by StemID and the associated cells per cluster.\
Figure 1---source data 3.List of differentially expressed genes between cardiomyocytes clusters 2 and 7 of the adult heart dataset.Only genes with a p-value\<0.05 are listed. Per gene, the log2 fold change, adjusted p-value (padj) and associated gene name are given. GO-terms for genes upregulated between clusters 2 and 7 (p\<0.01) are listed in separate excel sheets.](elife-50163-fig1){#fig1}

Border zone cardiomyocytes resemble embryonic cardiomyocytes {#s2-2}
------------------------------------------------------------

Cardiomyocytes in the border zone disassemble sarcomeric structures and re-express markers of embryonic cardiomyocytes suggesting their dedifferentiation. We therefore wanted to address the level of dedifferentiation of cluster seven cardiomyocytes by comparing their transcriptome with embryonic cardiomyocytes. To obtain embryonic cardiomyocytes we performed FACS sorting on embryos expressing the cardiomyocyte specific marker *Tg(myl7:GFP)*. Single-cell mRNA-sequencing was performed and combined with the single-cell data from the injured adult hearts ([Figure 2a](#fig2){ref-type="fig"}). The RaceID algorithm identified several cell clusters with separate clusters for the embryonic and adult cardiomyocytes ([Figure 2b, c and d](#fig2){ref-type="fig"}). Importantly, the cluster seven cardiomyocytes identified in the adult data analysis had a transcriptome that was highly similar to embryonic cardiomyocytes, as shown by pairwise correlation of the differentially expressed genes between the cardiomyocyte clusters: only 257 genes (p-value\<0.01), out of 23,786 total detected genes, were differentially expressed between the embryonic and the cluster 7 (border zone) adult cardiomyocytes ([Figure 2d](#fig2){ref-type="fig"} and [Figure 2---source datas 1](#fig2sdata1){ref-type="supplementary-material"}, [2](#fig2sdata2){ref-type="supplementary-material"}, [3](#fig2sdata3){ref-type="supplementary-material"} and [4](#fig2sdata4){ref-type="supplementary-material"}) suggesting a dedifferentiation of border zone cardiomyocytes to embryo\--like cells. In contrast, over 1000 genes (p-value\<0.01) were differentially expressed between embryonic and cluster 2 (remote zone) adult cardiomyocytes. A heatmap with unbiased hierarchical clustering on the 500 most differentially expressed genes between the three clusters confirmed that cluster 7 cardiomyocytes were more closely related to embryonic than cluster 2 cardiomyocytes ([Figure 2e](#fig2){ref-type="fig"}). Corroborating the observation that border zone cardiomyocytes resemble embryonic cardiomyocytes we found that genes encoding sarcomere proteins and cardiac-specific factors highly expressed in the embryo were re-expressed in cluster 7 (border zone) cardiomyocytes ([Figure 2f, g and h](#fig2){ref-type="fig"}).

![Single-cell transcriptome of border zone cardiomyocytes resembles that of embryonic cardiomyocytes.\
(**a**) Cartoon to illustrate the experimental procedure for single cell analysis of embryonic and adult cardiac cells. (**b**) tSNE map of combined adult (red) and embryonic datasets (light blue). (**c**) tSNE map indicating the different cell types based on marker gene expression. (**d**) tSNE map with the adult cardiomyocytes of the injured heart (cluster 7 in red, cluster 2 in blue and clusters 1 and 4 in gray) and embryonic (2 dpf) cardiomyocytes (in green), with number of pairwise differentially expressed genes (p-value\<0.01) indicated between cardiomyocyte clusters. (**e**) Heatmap with hierarchical clustering based on the 500 most differentially expressed genes between clusters. Red color represents high expression, blue color represents low expression. Rows represent individual genes. (**f--h**) tSNE maps visualizing log2-transformed read-counts of *vmhc* (**f**), *nppa* (**g**) and *tnnt2a* (**h**).\
Figure 2---source data 1.Single-cell mRNA sequencing data from *Tg(cmlc2:GFP*) zebrafish hearts at 2 days post fertilization.Raw reads are represented per gene (rows) and single cell (columns).\
Figure 2---source data 2.List of the clusters from the embryonic heart data (SD5) identified by StemID and the associated cells for each cluster.\
Figure 2---source data 3.Combined single-cell mRNA sequencing data from embryonic and adult hearts.Raw reads represented per gene (rows) and single cell (columns).\
Figure 2---source data 4.List of pairwise differentially expressed genes between all cardiomyocyte clusters from the combined embryonic and adult datasets.Only genes with a p-value\<0.01 are listed. Per gene, the log2 fold change, adjusted p-value (padj) and associated gene name are given. GO-terms for genes upregulated between clusters 5 and 6 (p\<0.01) are listed in separate excel sheets.](elife-50163-fig2){#fig2}

To identify cellular events that occur during this dedifferentiation we used part of the RaceID algorithm (StemID) that uses the single cell transcriptome data and cell clustering to derive a branched lineage tree ([@bib22]). The algorithm is based on the premise that stem cells and less differentiated cells tend to exhibit more uniform transcriptomes than differentiated cells, which express smaller numbers of genes at higher rates ([@bib1]). Using this approach, we found large differences in transcriptome entropy, resulting in low (cluster 2), intermediate (clusters 1 and 4) and high (cluster 7) StemID scores ([Figure 3a](#fig3){ref-type="fig"}). This gradual increase suggests a dedifferentiation axis from cells in cluster 2 (remote myocardium) to cells in cluster 7 (border zone myocardium) and is in good agreement with our finding that the transcriptome of cluster 7 cardiomyocytes resembles an embryonic cardiomyocyte transcriptome ([Figure 3b](#fig3){ref-type="fig"}). Together, these results indicate that clusters 4 and 7 are enriched for dedifferentiated and proliferative border zone cardiomyocytes while clusters 1 and 2 are enriched for differentiated remote cardiomyocytes.

![Pseudo time analysis reveals dedifferentiation and metabolic changes in border zone cardiomyocytes.\
(**a**) Bar plot of StemID scores for the cardiomyocyte clusters (clusters \#2, 1, 4 and 7) calculated by the formula: number of significant links for each cluster multiplied by the median transcriptome entropy across all cells in a cluster. (**b**) Cardiomyocyte clusters from adult injured heart. Arrow indicates the dedifferentiation path derived from the StemID scores. (**c**) Pseudo time analysis. Left; one-dimensional SOM of z-score transformed expression profiles along the differentiation trajectory incurred by StemID analysis. Y-axis represents the fourteen modules with differentially expressed genes. X-axis represents the pseudo time in which the cells were ordered. Middle; expression profiles of representative genes of the major modules. Y-axis shows transcript counts. X-axis represents the pseudo time. Right; Major gene ontology terms derived from all genes expressed in the module with p-values.\
Figure 3---source data 1.List of genes that are differentially upregulated in the respective modules identified in the pseudo timeline analysis (related to [Figure 3c](#fig3){ref-type="fig"}).](elife-50163-fig3){#fig3}

Border zone cardiomyocytes induce glycolysis, which is required for proliferation {#s2-3}
---------------------------------------------------------------------------------

While cardiomyocytes undergo a well-defined sequence of morphological and transcriptional changes during differentiation, very little is known about the reverse process. Ordering whole-transcriptome profiles of single cells with an unsupervised algorithm can resolve the temporal resolution during differentiation by identifying intermediate stages of differentiation without a priori knowledge of marker genes ([@bib68]). In this manner, the single-cell mRNA-seq experiment will constitute an in-silico time series, with each cell representing a distinct state of differentiation along a continuum. To analyze the transcriptional changes occurring during this apparent dedifferentiation, the most likely dedifferentiation path, based on the StemID scores, was chosen starting at cluster two and progressing through clusters 1, 4 and 7. Next, gene expression profiles along this pseudo-temporal order were computed for all detected genes using the single-cell transcriptomes. These gene expression profiles were grouped into modules of co-expressed genes using self-organizing maps (SOMs), resulting in 14 modules ([Figure 3c](#fig3){ref-type="fig"}, [Figure 3---source data 1](#fig3sdata1){ref-type="supplementary-material"}). Corroborating our hypothesis of varying differentiation states, we observed that gene expression within these modules changed smoothly over pseudo time. We next analyzed the temporally-ordered expression profiles and identified four groups of genes that shared the same dynamics of expression during this differentiation trajectory. The first group (modules 1, 2) contained genes that were most highly expressed only in cells at the very beginning of the pseudo time line and their expression rapidly declined in cells that were positioned later. This group contained many genes transcribed from mitochondrial DNA and with a role in energy metabolism, which indicates that the cells at the start of the pseudo time line are mature cardiomyocytes. The second group (module 6) contained genes that are induced early and expression stayed constant in cells further along the pseudo time line. Many genes involved in translation and cell cycle regulation follow this expression pattern. The third group showed an exponential increase in expression with the highest expression at the end of the pseudo time line (module 10). This group contained genes with a function in cardiac muscle fiber development and heart contraction. The fourth group (modules 11 and 14) contained genes with a rapid increase in expression that peaks before the end of the pseudo time, suggestive for an early role during the dedifferentiation process. Interestingly this group contained many genes with a known role in glycolysis. Together, these data suggest that border zone cardiomyocytes undergo profound metabolic changes. This was confirmed by GO-term analysis between cluster 7 and cluster 2 cells ([Figure 4---figure supplement 1a and b](#fig4s1){ref-type="fig"}, [Figure 1---source data 3](#fig1sdata3){ref-type="supplementary-material"}).

To validate the functional consequences of the observed changes in mitochondrial gene expression, we measured succinate dehydrogenase (SDH) enzyme activity, located in the inner mitochondrial membrane that functions in both the citric acid cycle and electron transport chain. We observed a 40% reduction in SDH activity specifically in the border zone cardiomyocytes as compared to the remote cardiomyocytes ([Figure 4a](#fig4){ref-type="fig"}). In agreement with the reduced mitochondrial OXPHOS activity, transmission electron microscopy (TEM) imaging revealed more immature mitochondria in border zone cardiomyocytes evidenced by their altered morphology and reduced cristae density ([Figure 4b](#fig4){ref-type="fig"}), which is consistent with previous reports linking mitochondrial function with morphology ([@bib18]; [@bib49]). Since the pseudotime analysis suggested an upregulation of glycolytic gene expression in the border zone cluster (\#7), we performed gene set enrichment analysis (GSEA) for glycolysis genes. The GSEA revealed a strong and significant enrichment in the expression of glycolytic genes in cluster 7 cells compared to cluster 2 cells ([Figure 4---figure supplement 1c](#fig4s1){ref-type="fig"}). By in situ hybridization we confirmed the induced expression in border zone cardiomyocytes of the rate-limiting enzymes hexokinase (*hk1*), pyruvate kinase M1/M2a (*pkma*) and pyruvate dehydrogenase kinase (*pdk2a*), which diverts pyruvate away from the TCA cycle ([Figure 4c](#fig4){ref-type="fig"} and [Figure 1---figure supplement 4b](#fig1s4){ref-type="fig"}). Corroborating the suggested enhanced glycolysis, we observed induced expression of glucose importer genes (*glut1a/slc2a1a* and *glut1b/slc2a1b*) in cluster 7 cells ([Figure 4---figure supplement 1d](#fig4s1){ref-type="fig"}) and enhanced in vivo glucose uptake of border zone cardiomyocytes ([Figure 4d](#fig4){ref-type="fig"}). Furthermore, genes encoding lactate transporters and their proteins were upregulated in cluster seven and border zone cardiomyocytes ([Figure 4e](#fig4){ref-type="fig"} and [Figure 4---figure supplement 1d](#fig4s1){ref-type="fig"}). Together, these data indicate that during regeneration border zone cardiomyocytes switch energy metabolism from mitochondrial OXPHOS to glycolysis and lactate fermentation.

![Border zone cardiomyocytes undergo a metabolic switch from mitochondrial OXPHOS to glycolysis.\
(**a**) Succinate dehydrogenase (SDH) enzyme staining on a seven dpi heart section with injury area separated by dashed line. Quantification of SDH activity in remote zone (RZ), border zone (BZ) and injury area (IA). Scale bar indicates 100 μm. Error bars indicate mean and standard deviation. (**b**) Transmission electron microscopy (TEM) images of mitochondria in cardiomyocytes from the remote zone and the border zone of a 7 dpi injured heart. Note the disorganized and irregular shaped mitochondria in the border zone cardiomyocyte. Scale bar 500 nm (200 nm in inserts). Graphs show quantification of mitochondrial perimeter-to-area as a measurement for roundness and quantification of mitochondrial cristae density. \* p-value\<0.05. (**c**) In situ hybridizations for glycolytic genes *hk1*, *pkma* and *pdk2a* on sections of injured zebrafish hearts at 7 dpi. Dashed line indicates injury site. Scale bars indicate 100 μm. (**d**) Time-lapse multi-photon confocal images of whole heart. The heart was isolated at 7 dpi and incubated with 2-NBDG, a fluorescent glucose analogue, at t = 0. Dotted line indicates injury area. Arrows point to regions of the border zone. Scale bar represents 100 μm. (**e**) Confocal image of injured zebrafish hearts at 7 dpi stained for the lactate transporter MCT4 (green) and Tropomyosin (red). Dashed line indicates injury site.](elife-50163-fig4){#fig4}

The pseudo time line analysis suggested that glycolysis genes induction precedes the induction of embryonic cardiac gene expression. Indeed, ISH analysis showed that glycolysis gene expression is already induced at 3 dpi and thereby precedes expression of embryonic cardiac gene expression and cardiomyocyte proliferation, which peaks at 7 dpi ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). To address the functional importance of glycolysis we inhibited glycolysis in injured fish with the glucose analogue 2-Deoxyglucose (2-DG), a general inhibitor of glycolysis, and analyzed its effect on cardiomyocyte proliferation ([Figure 5a](#fig5){ref-type="fig"}). We observed that repeated injections of 2-DG in the adult zebrafish with a cryoinjured heart significantly impaired cardiomyocyte proliferation in the border zone ([Figure 5b,c](#fig5){ref-type="fig"}), suggesting that glycolysis is necessary for cell cycle reentry.

![2-Deoxy glucose impairs cardiomyocyte proliferation.\
(**a**) Experimental design for the 2-DG injections to inhibit glycolysis in injured zebrafish hearts. (**b**) Confocal image of injured zebrafish hearts at seven dpi either injected with PBS or 2-DG stained for Mef2c (green) and PCNA (magenta). Zoom-in images of the borderzone are shown below overview pictures for both PBS (cyan box) and 2-DG (orange box). Arrowheads indicate nuclei positive for Mef2c and PCNA. Scale bar indicates 200 μm (overview) or 20 μm (zoom-in). (**c**) Quantification of the proliferating cardiomyocytes (double Mef2c/PCNA positive) in the border zone of PBS and 2-DG treated hearts represented as the proportion of proliferating cardiomyocytes compared to the average percentage in the PBS injected group. Each dot represents a single heart (three sections per heart analyzed). Hearts were pooled from two separate experiments. Error bars represent mean ± standard deviation. \*\*\*, p\<0,0001.](elife-50163-fig5){#fig5}

Nrg1/ErbB2 signaling induces glycolytic gene expression in border zone cardiomyocytes {#s2-4}
-------------------------------------------------------------------------------------

Next, we investigated the upstream signals that drive the observed metabolic reprogramming in border zone cardiomyocytes during cell cycle reentry. Hypoxia is a well-known stimulus for metabolic reprogramming during cancer and promotes cardiomyocyte proliferation during cardiac regeneration ([@bib30]; [@bib47]; [@bib70]). The responses to hypoxia are induced by the transcription factor, hypoxia inducible factor (HIF), whose activity can be visualized using the *Tg(phd3:GFP)* reporter line ([@bib56]; [@bib71]). When analysing cryo-injured hearts of *Tg(phd3:GFP)* fish 7 days post injury we did not observe a good correlation between pdh3:GFP reporter activity and the induction of *ldha* expression in border zone cardiomyocytes suggesting that HIF signaling is not required for the observed induction of glycolysis gene expression in border zone cardiomyocytes ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). Injury-induced Neuregulin 1 (Nrg1) expression is another potent mitogen that induces cardiomyocyte dedifferentiation and cell cycle reentry by activating ErbB2 receptor signaling ([@bib16]). Furthermore, in vitro experiments suggest that Nrg1 can induce glucose metabolism ([@bib10]; [@bib65]). To address whether Nrg1 can induce metabolic reprogramming in vivo, we used a previously described transgenic zebrafish model in which Nrg1 overexpression (OE) can be induced in a heart specific manner, *tg(cmlc2:CreER; β-act2:BSNrg1)* ([@bib16]). In this model especially cortical cardiomyocytes start to divide after tamoxifen injection leading to thickening of this layer. We observed a profound and consistent upregulation of glycolysis genes in the cortical myocardium coinciding with the reported cardiomyocyte dedifferentiation and proliferation in this layer ([Figure 6a](#fig6){ref-type="fig"}). Expression of *ldha* and *hk1*, encoding the rate limiting glycolytic enzyme hexokinase, was strongly induced in the ventricular wall of Nrg1 OE hearts, which correlates well with the observed induction of cardiomyocyte dedifferentiation and proliferation in this region ([@bib16]). Next, we assessed whether blocking Nrg1/ErbB2 signaling impairs glycolytic upregulation in the zebrafish border zone after cryoinjury. qPCR confirmed the profound upregulation of glycolytic genes in border zone cardiomyocytes compared to their expression in cardiomyocytes from uninjured hearts ([Figure 6b](#fig6){ref-type="fig"}). Importantly the ErbB2 inhibitor AG1478 inhibited the induction of glycolytic gene expression in border zone cardiomyocytes ([Figure 6b](#fig6){ref-type="fig"}). In contrast to the other glycolysis genes, *hk1* expression was not reduced after AG1478 treatment likely as a result of redundant signaling pathways in the border zone. From these results, we conclude that glycolysis gene expression can be induced by Nrg1/ErbB2 signaling even in the absence of cardiac injury and that endogenous Nrg1/ErbB2 signaling is an important mediator of metabolic rewiring during zebrafish heart regeneration.

![Nrg1/ErbB2 signaling induces glycolysis genes in zebrafish and mouse.\
(**a**) Cartoon showing experimental procedure to induce cardiomyocyte specific Nrg1 expression in zebrafish. Panels show in situ hybridization for *hexokinase 1* (*hk1*) and *lactate dehydrogenase a* (*ldha*) expression on sections of control hearts (*β-act2:BSNrg1*) and Nrg1 OE hearts (*cmlc2:CreER; β-act2:BSNrg1*). Scale bars represent 100 μm. (**b**) qPCR results for glycolytic genes showing their relative fold change in DMSO treated (n = 9) (blue) and AG1478 treated (n = 9) (green) nppa:mCitrine high border zone cardiomyocytes at 3dpi compared to uninjured adult cardiomyocytes (n = 4) (yellow). Error bars represent standard deviation. (**c**) Upper panel: Cartoon showing the experimental procedure to analyse metabolic gene expression after activating ErbB2 signaling in the murine heart. Lower panel: qPCR results for metabolic genes showing their relative fold change in caErbB2 OE (n = 4) heart compared to control WT hearts (n = 4). Error bars represent standard deviation. (**d**) Immunohistochemistry for phospho-PDH3 on sections of control and caErbB2 OE hearts. Scale bars represent 100 μm. \*=p \< 0.05, \*\*=p \< 0.01, \*\*\*=p \< 0.001, \*\*\*\*=p \< 0.0001.\
Figure 6---source data 1.Oligonucleotide sequences for real-time PCR analysis.](elife-50163-fig6){#fig6}

Activating ErbB2 signaling induces a metabolic switch from OXPHOS to glycolysis and lactate fermentation in murine cardiomyocytes {#s2-5}
---------------------------------------------------------------------------------------------------------------------------------

The regenerative capacity of the adult murine heart is very low, but cardiomyocyte dedifferentiation and proliferation can be stimulated by cardiomyocyte specific overexpression of a constitutively active ErbB2 receptor (caErbB2 OE) ([@bib11]). To address whether this is correlated with metabolic changes we performed qPCRs for metabolic genes on cardiac tissue from caErbB2 mice. Indeed, we observed that critical glycolysis genes (e.g. *Pfkp, Pdk3 and Pkm2*) including glucose and lactate transporters (*Slc16A3* and *Slc2A1*) were significantly upregulated in caErbB2 OE cardiomyocytes while genes transcribed from mitochondrial DNA were downregulated ([Figure 6c](#fig6){ref-type="fig"}). *Pdk3* encodes a pyruvate dehydrogenase kinase, which phosphorylates pyruvate dehydrogenase (PDH). PDH is a mitochondrial multi-enzyme complex that converts pyruvate to Acetyl-CoA and provides a primary link between glycolysis and the TCA cycle. Upon phosphorylation by PDK, p-PDH is inactivated and pyruvate is diverted away from the TCA cycle resulting in enhanced lactate production. Consistent with the increase in *pdk3* expression, an increased phosphorylation of PDH was observed in the inner myocardial layer of caErbB2 OE hearts ([Figure 6d](#fig6){ref-type="fig"}).

Next, we addressed whether the observed switch in metabolic gene expression correlated with enhanced regenerative capacity after injury. Therefore, we performed myocardial infarction (MI) in wild type and caErbB2 OE hearts. Even though glucose uptake and glycolytic enzyme activity in the ischemic area are increased by MI ([@bib57]) ([@bib48]), we observed a stronger upregulation of glycolytic gene expression and decreased mitochondrial gene expression in caErbB2 OE hearts with MI compared to wild type hearts with MI ([Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}). This stronger and consistent upregulation of glycolytic gene expression in caErbB2 OE hearts correlates with the reported enhanced cardiomyocyte proliferation and improved regeneration ([@bib11]). These findings imply that the enhanced glucose uptake and anaerobic glycolysis observed after MI might be sufficient for cell survival, but that a stronger induction of glycolysis gene expression is required to fully stimulate cardiomyocyte proliferation and regeneration.

CaErbB2 induced cardiomyocyte proliferation depends on glycolysis {#s2-6}
-----------------------------------------------------------------

Finally, we addressed whether the observed metabolic switch to glycolysis in caErbB2 OE cardiomyocytes is required for their reentry into the cell cycle ([Figure 7a](#fig7){ref-type="fig"}). Corroborating our model, we indeed observed that treating caErbB2 OE cardiomyocytes in vitro with the glycolysis inhibitors 2-DG or lonidamine strongly and significantly impaired cell cycle reentry ([Figure 7b and c](#fig7){ref-type="fig"}) and cytokinesis ([Figure 7d and e](#fig7){ref-type="fig"}). Together these results indicate that in murine cardiomyocytes, ErbB2 signaling drives a metabolic switch towards glycolysis, which is required for their cell cycle reentry. These results suggest that this metabolic switch in cardiomyocytes is beneficial for heart regeneration.

![Glycolysis inhibitors impair mitogenic effect of ErbB2 activation in cardiomyocytes.\
(**a**) Cartoon showing the experimental procedure to analyse the effects of glycolysis inhibitors (2-DG and lonidamine) on cardiomyocyte proliferation. (**b**) Immunofluorescence analysis on P7 cardiac cultures derived from WT and caErbB2 OE hearts that are endogenously fluorescent for tdTomato under the *MYH6* promoter, stained for the cell-cycle marker Ki67. Arrows point at Ki67+ CMs. (**c**) Quantification of % Ki67+ CMs from WT and caErbB2 OE derived from P7 cardiac cultures treated with the glycolysis inhibitors 2-DG (n = 4 for WT and n = 4 for OE), and lonidamine (n = 7 for WT and n = 4 for OE) or their diluents as controls. (**d**) Immunofluorescence analysis on P7 cardiac cultures derived from WT and caErbB2 OE hearts that are endogenously fluorescent for tdTomato under the *MYH6* promoter, stained for the cytokinesis marker Aurora kinase B. Arrows point at Aurkb+ CMs. (**e**) Quantification of % Aurkb+ CMs from WT and caErbB2 OE derived from P7 cardiac cultures treated with the glycolysis inhibitors 2-DG (n = 4 for WT and n = 4 for OE), and lonidamine (n = 7 for WT and n = 4 for OE) or their diluents as controls. In all panels, bars represent the mean, and error bars represent s.e.m \*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001, \*\*\*\*p\<0.0001, Scale bars represent 50 μm.](elife-50163-fig7){#fig7}

Discussion {#s3}
==========

Heart regeneration in zebrafish is very efficient and relies on the proliferation of preexisting cardiomyocytes. The number of proliferating cardiomyocytes that is induced by injury is very small and they comprise only a small portion of the total cardiomyocytes, which has hampered their characterization. Thus far, RNA-seq data sets and differential gene analysis was based on whole tissue preparations or cryosections of uninjured and injured hearts ([@bib19] [@bib31]; [@bib36]; [@bib38]; [@bib61]; [@bib73]). Not only cardiomyocytes but other cell types in the heart such as epicardial and endocardial cells respond to the injury by the upregulation of injury-induced genes ([@bib37]). Furthermore, the injured heart is infiltrated by immune cells and fibroblasts appear ([@bib20]; [@bib36]). Together, this complicates the detection of cardiomyocyte specific gene responses. The use of single cell transcriptomics can overcome these limitations and has allowed us to identify and characterize the different cardiomyocyte populations in the regenerating zebrafish heart. Here we have generated a unique RNA-seq dataset at single-cell resolution of cardiomyocytes during heart regeneration, which can be used as a resource to study and identify novel mechanisms.

Activation of Yap signaling in the murine heart promotes cardiomyocyte proliferation, which involves a partial reprogramming and dedifferentiation of adult cardiomyocytes towards a neonatal fate ([@bib44]). Interestingly, single-cell RNA-seq analysis of connective tissue cells during limb blastema formation revealed that their transcriptome is highly similar to embryonic limb precursor cells ([@bib17]). Together with our results that a similar reprogramming takes place during injury induced heart regeneration in zebrafish it suggests a common theme in which adult tissues that lack a clear stem cell use an alternative strategy to regenerate the missing tissue by reprogramming differentiated cells into embryo-like cells. This might involve different mechanisms since Yap signaling is not required for cardiomyocyte proliferation during zebrafish heart regeneration ([@bib14]). The presence of embryo-like cardiomyocytes in the border zone after injury can explain the observed switch from trabecular cardiomyocytes into cortical cardiomyocytes during zebrafish heart regeneration, since embryonic cardiomyocytes give rise to both trabecular and cortical cardiomyocytes ([@bib55]; [@bib63]).

Increased mitochondrial OXPHOS activity promotes cardiomyocyte maturation and reduces the proliferative capacity of cardiomyocytes ([@bib43]). This correlates well with the loss of regenerative capacity of the murine heart in the first week after birth at which time the metabolism in cardiomyocytes changes from predominantly glycolysis to mitochondrial OXPHOS ([@bib39]; [@bib42]; [@bib51]). Reactive oxygen species (ROS) generated by mitochondrial OXPHOS induce DNA damage causing cardiomyocyte cell-cycle arrest ([@bib47]; [@bib54]; [@bib66]). Our pseudo time line analysis shows a rapid downregulation of mitochondrial gene expression together with an increase in genes encoding glucose transporters, glycolytic enzymes and lactate transporters. A direct role for glycolysis and lactate fermentation in cardiomyocyte proliferation had not been addressed and our results that pharmacological inhibition of glycolysis impairs cardiomyocyte proliferation suggest that activation of glycolysis can drive the reprogramming of cardiomyocytes. It also raises the question why cardiomyocytes need to switch their metabolism to glycolysis to reenter the cell cycle? Interestingly, a similar metabolic shift from mitochondrial OXPHOS to glycolysis and lactate fermentation occurs in proliferating tumor cells, and was first described by Otto Warburg ([@bib72]). Since this glucose to lactate transformation occurs regardless of whether oxygen is present it is referred to as aerobic glycolysis. While glycolysis generates much less ATP compared to fatty acid oxidation, it is thought that glycolysis and the connected pentose-phosphate pathway provides essential metabolites that are needed to create sufficient biomass to sustain proliferation of the tumor cells ([@bib70]). Furthermore, progenitor cells in the developing embryo as well as induced pluripotent stem cells depend on glycolysis to maintain proliferation and their potency ([@bib15]; [@bib23]; [@bib41]). In addition, glycolytic enzymes such as PKM2 and PFKFB4 can also directly interact with cell cycle regulators to promote proliferation ([@bib75]; [@bib12]). The precise role for glycolysis in driving the cellular reprogramming during heart regeneration needs to be further investigated using genetic loss- and gain-of-function experiments combined with metabolomics, which is challenging given the low number of proliferating cardiomyocytes in the regenerating heart.

Activation of Nrg1/ErbB2 signaling in either zebrafish or mouse hearts induces cardiomyocyte dedifferentiation and proliferation ([@bib11]; [@bib16]). Our results build upon these observations and indicate that Nrg1/ErbB2 signaling induces profound metabolic reprogramming in cardiomyocytes and that this is required for efficient cardiomyocyte proliferation. Future work should address how Nrg1/ErbB2 signaling induces metabolic reprogramming in cardiomyocytes, which could have important implications for stimulating mammalian heart regeneration ([@bib50]).

Materials and methods {#s4}
=====================

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\                               Designation                                              Source or\                                                                                                                           Identifiers                                                                         Additional\
  (species) or\                                                                                        reference                                                                                                                                                                                                                information
  resource                                                                                                                                                                                                                                                                                                                      
  ------------------------------------------- -------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------ ----------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Strain, strain background (*Danio rerio*)   Tupfel Long Fin (TL)                                     ZIRC                                                                                                                                 ZDB-GENO-990623--2                                                                  

  Genetic reagent (*Danio rerio)*             Tg(*myl7*:dsRED)^s879Tg^                                 [@bib8]                                                                                                                              ZDB-FISH-150901--3078                                                               

  Genetic reagent (*Danio rerio)*             Tg(*myl7*:GFP)^twu34Tg^                                  [@bib28]                                                                                                                             ZDB-FISH-150901--212                                                                

  Genetic reagent (*Danio rerio)*             Tg(*phd3:*GFP)^sh144^                                    [@bib56]                                                                                                                             ZDB-FISH-150901--26851                                                              

  Genetic reagent (*Danio rerio)*             Tg(*gata4:*EGFP)^ae1^                                    [@bib27]                                                                                                                             ZDB-FISH-150901--14762                                                              

  Genetic reagent (*Danio rerio*)             TgBAC(*nppa:mCitrine)*                                   This paper                                                                                                                                                                                                               More info on generation of this line can be obtained from the Materials and methods section 'Transgenic zebrafish lines and cryoinjury'.

  Cell line (*Mus musculus*)                  TetRE-caErbb2 X MYH6-tTA X MYH6-cre ROSA26-tdTomato      [@bib11]                                                                                                                                                                                                                 More info on how to obtain primary cell line can be obtained from Materials and methods sections 'Transgenic mouse lines and animal procedures' and 'Pharmacological inhibition of glycolysis'.

  Biological sample (*Mus musculus*)          TetRE-caErbb2 X MYH6-tTA hearts                          [@bib11] from:\                                                                                                                      The Jackson Laboratory, stock no. 010577;                                           
                                                                                                       [@bib74] and\                                                                                                                                                                                                            
                                                                                                       [@bib76].                                                                                                                                                                                                                

  Biological sample (*Danio rerio*)           Tg(cmlc2:CreER)^pd10^ x Tg(β-act2:BSNrg1)^pd107^hearts   [@bib16]                                                                                                                             ZDB-FISH-150901--25249\                                                             
                                                                                                                                                                                                                                            x\                                                                                  
                                                                                                                                                                                                                                            ZDB-FISH-150901--25354                                                              

  Biological sample (*Danio rerio*)           Tg(*gata4:*EGFP)^ae1^hearts                              Lin et al. 2009                                                                                                                      ZDB-FISH-150901--14762                                                              

  Biological sample (*Danio rerio)*           Tg(phd3:GFP)^sh144^hearts                                [@bib56]                                                                                                                             ZDB-FISH-150901--26851                                                              

  Antibody                                    Anti-AuroraB kinase (mouse monoclonal)                   BD Transduction Laboratories                                                                                                         \#611082, RRID:[AB_2227708](https://scicrunch.org/resolver/AB_2227708)              1:200

  Antibody                                    Anti-Ki67 (Rabbit monoclonal)                            Cell Marque                                                                                                                          \#275R                                                                              1:200

  Antibody                                    Anti-MCT4 (rabbit polyclonal)                            Santa Cruz                                                                                                                           \#SC50329, RRID:[AB_2189333](https://scicrunch.org/resolver/AB_2189333)             1:200

  Antibody                                    Anti-PCNA (mouse monoclonal)                             DAKO                                                                                                                                 \#M0879, RRID:[AB_2160651](https://scicrunch.org/resolver/AB_2160651)               1:800

  Antibody                                    Anti-GFP (chicken polyclonal)                            Aves                                                                                                                                 \#GFP-1010, RRID:[AB_2307313](https://scicrunch.org/resolver/AB_2307313)            1:1000

  Antibody                                    Anti-Mef2C (rabbit polyclonal)                           Santa Cruz/Biorbyt                                                                                                                   \#SC313, RRID:[AB_631920](https://scicrunch.org/resolver/AB_631920) / \#orb256682   Both 1:1000

  Chemical compound, drug                     2-Deoxyglucose                                           Sigma-Aldrich                                                                                                                        \#D6134                                                                             1 mg/g or 3 mM

  Chemical compound, drug                     Lonidamine                                               Sigma-Aldrich                                                                                                                        L4900                                                                               80 uM

  Chemical compound, drug                     2NBDG                                                    Caymanchem                                                                                                                           \#11046                                                                             400 uM

  Chemical compound, drug                     AG1478                                                   Selleck Chemical                                                                                                                     S2728                                                                               5M, from 10 mM stock in DMSO

  Chemical compound, drug                     Doxycycline                                              Harlan Laboratories                                                                                                                  TD02503                                                                             

  Chemical compound, drug                     Trizol                                                   Life technologies                                                                                                                    \#15596026                                                                          

  Chemical compound, drug                     Fast SYBR Green Master Mix                               Applied Biosystems                                                                                                                   \#4385612                                                                           

  Chemical compound, drug                     Collagenase type II                                      Gibco                                                                                                                                17101015                                                                            0.1%

  Chemical compound, drug                     TrypLE Express Enzyme (1x), phenol red                   Gibco                                                                                                                                12605036                                                                            

  Software, algorithm                         FIJI                                                     [@bib58]                                                                                                                             Version 2.0.0, RRID:[SCR_002285](https://scicrunch.org/resolver/SCR_002285)         

  Software, algorithm                         RaceID2/StemID                                           Grün, D. et al. De Novo Prediction of Stem Cell Identity using Single-Cell Transcriptome Data. Cell Stem Cell 19, 266--277 (2016).   RRID:[SCR_017242](https://scicrunch.org/resolver/SCR_017242)                        

  Software, algorithm                         Rstudio                                                  Rstudio                                                                                                                              RRID:[SCR_000432](https://scicrunch.org/resolver/SCR_000432)                        Version 1.2.1335

  Software, algorithm                         Imaris                                                   Bitplane                                                                                                                             RRID:[SCR_0007370](https://scicrunch.org/resolver/SCR_0007370)                      V9.3.1

  Software, algorithm                         Gene Set Enrichment Analysis                             Genepattern, Broad Institute                                                                                                         RRID:[SCR_003199](https://scicrunch.org/resolver/SCR_003199)                        \# of permutations = 1000

  Commercial assay, kit                       Superscript III First strand synthesis system            Thermo Fisher Scientific                                                                                                             \#18080051                                                                          Input 200 ng RNA

  Commercial assay, kit                       MiRNeasy                                                 Qiagen                                                                                                                               217004                                                                              

  Commercial assay, kit                       High capacity cDNA Reverse Transcription kit             Applied Biosystems                                                                                                                   4374966                                                                             Input 1 ug RNA

  Commercial assay, kit                       Neonatal Dissociation kit                                Miltenyi Biotec                                                                                                                      130-098-373                                                                         

  Commercial assay, kit                       TruSeq small RNA primers                                 Illumina                                                                                                                             20005613                                                                            
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Transgenic zebrafish lines and cryoinjury {#s4-1}
-----------------------------------------

The following fish lines were used: TL, Tg(*phd3*:GFP), Tg(*gata4:*EGFP)^ae1^ and myl7:GFP^twu34Tg^ ([@bib28]) ([@bib32]; [@bib56]). The *Tg(cmlc2:CreER; β-act2:BSNrg1)* line was used as described before ([@bib16]). The *TgBAC*(*nppa*:mCitrine) line was generated essentially as described previously ([@bib5]). In short, an iTOL2_amp cassette for pTarBAC was inserted in the vector sequence of bacterial artificial chromosome (BAC) CH211-70L17, which contains the full *nppa* locus. Subsequently, a mCitrine_kan cassette was inserted at the ATG start codon of the first exon of the nppa gene. Amplification from a pCS2+mCitrine_kanR plasmid was achieved with primers:

FWD_NPPA_HA1_GFP

5′-gagccaagccagttcagagggcaagaaaacgcattcagagacactcagagACCATGGTGAGCAAGGGCGAGG-3′ and REV_NPPA_HA2_NEO

5′-gtctgctgccaaaccaggagcagcagtcctgtcagaattagtcccccggcTCAGAAGAACTCGTCAAGAAGGCGATAGAA −3'.

Sequences homologous to the BAC are shown in lower case. Recombineering was performed following the manufacturer's protocol (Red/ET recombination; Gene Bridges GmbH, Heidelberg, Germany) with minor modifications. BAC DNA isolation was carried out using a Midiprep kit (Life Technologies BV, Bleiswijk, The Netherlands). BAC DNA was injected at a concentration of 300 ng/µl in the presence of 25 ng Tol2 mRNA. At three dpf, healthy embryos displaying robust nppa-specific fluorescence in the heart were selected and grown to adulthood. Subsequently, founder fish were identified by outcrossing and their progeny grown to adulthood to establish the transgenic line.

Zebrafish of \~4 to 18 months of age (males and females, TL strain) were used for regeneration experiments. Cryoinjuries were performed as previously described ([@bib59]), except that a liquid nitrogen-cooled copper filament of 0.3 mm diameter was used instead of dry ice.

Sample sizes were chosen to accommodate the generally accepted standards in the field: five or more cryoinjured hearts per condition.

Animals were only excluded from experiments in case of severe sickness/infection/aberrant behavior (according to animal experiment guidelines).

Transgenic mouse lines and animal procedures {#s4-2}
--------------------------------------------

Doxycycline-inducible CM-restricted overexpression of a constitutively active Erbb2 (caErbb2) was generated by crossing the TetRE--caErbb2 ([@bib74]) mouse line with *MYH6*-- tTA which expresses the tetracycline-responsive transcriptional activator (tTA) under the control of the human alpha myosin heavy chain promoter (*MYH6*) ([@bib76]). Doxycycline (DOX, Harlan Laboratories, TD02503) was administered in the food to repress transgene expression. For cultures derived of OE/WT hearts, we additionally intercrossed the *MYH6*-cre ROSA26-tdTomato transgenes in order to visualize CMs.

For myocardial infarction, mice were sedated with isoflurane (Abbott Laboratories) and were artificially ventilated following tracheal intubation. Experimental myocardial infarction was induced by ligation of the left anterior descending coronary artery (LAD ligation). Following the closure of the thoracic wall mice were warmed for several minutes until recovery.

Immunofluorescence {#s4-3}
------------------

ADULT: For immunofluorescence, hearts were extracted, fixed in 4% PFA at room temperature for 1,5 hr and cryosectioned into 10 µm sections. Heart sections were equally distributed onto seven serial slides so each slide contained sections representing all areas of the ventricle.

Primary antibodies used were anti-AuroraB kinase (BD Transduction laboratories \#611082, 1:200), anti-Ki67 (Cell Marque \#275R, 1:200), anti-MCT4 (Santa Cruz \#SC50329, 1:200), anti-PCNA (Dako \#M0879, 1:800), anti-GFP (aves \#GFP-1010, 1:1000), and anti-Mef2c (Santa Cruz \#SC313, Biorbyt \#orb256682 both 1:1000). Antigen retrieval was performed by heating slides containing heart sections at 85°C in 10 mM sodium citrate buffer (pH 6) for 10 min. Secondary antibodies conjugated to Alexa 488 (ThermoFisher Scientific), Cy3 or Cy5 (Jackson Laboratories) were used at a dilution of 1:1000. Nuclei were shown by DAPI (4',6-diamidino-2-phenylindole) staining. Images of immunofluorescence stainings are single optical planes acquired with a Leica Sp8 or Sp5 confocal microscope. Quantifications of PCNA, Mef2, and mCitrine expression were performed in cardiomyocytes situated within 150 µm from the wound border on 3 sections of \>4 hearts. Sections were masked before quantification.

EMBRYONIC: Live embryos were immobilized using ms222 and embedded in nitrocellulose + E3 to be mounted on a Leica SPE confocal microscope, followed by a Z-stack maximum projection (step size 2 µm).

MAMMALIAN P7 CARDIAC CULTURES: For immunofluorescence, cardiac cultures were fixed with 4% PFA for 10 min on room temperature on the shaker, followed by permeabilization with 0.5% Triton X-100 in PBS for 5 min, and blocking with 5% bovine serum albumin (BSA) in PBS containing 0.1% Triton for 1 hr at room temperature. Masking was performed before quantification.

Quantitative PCR {#s4-4}
----------------

ADULT ZEBRAFISH: *nppa:*mCitrine zebrafish were cryoinjured and received two overnight pulses of DMSO (1:2000) or 5 µM AG1478 (10 mM stock in DMSO; Selleck Chemical, Houston, TX) from 1dpi to 2dpi and from 2dpi to 3dpi. Then, hearts were extracted for both conditions (n = 9) as well as uninjured *cmlc2:*dsRED controls (n = 4), dissociated and single cells were FACS sorted for mCitrine and dsRED expression respectively. RNA was isolated from sorted cells using Trizol (Life Technologies BV, Bleiswijk, The Netherlands). RNA was quantified using a NanoDrop spectrophotometer. Superscript III First Strand Synthesis System (ThermoFisher Scientific) was used to reverse transcribe 200 ng of purified RNA per condition following manufacturer's protocol. qPCR reactions were performed using Fast SYBR Green PCR Master Mix (Applied Biosystems). Oligonucleotide sequences for real-time PCR analysis performed in this study are listed in [Figure 6---source data 1](#fig6sdata1){ref-type="supplementary-material"}.

MOUSE: RNA from whole hearts was isolated using the MiRNeasy kit (Qiagen, 217004), according to the manufacturer's instructions. RNA was quantified using a NanoDrop spectrophotometer. A High Capacity cDNA Reverse transcription kit (Applied Biosystems, 4374966) was used to reverse transcribe 1 µg of purified RNA according to the manufacturer's instructions. qPCR reactions were performed using Fast SYBR Green PCR Master Mix (Applied Biosystems). Oligonucleotide sequences for real-time PCR analysis performed in this study are listed in [Figure 6---source data 1](#fig6sdata1){ref-type="supplementary-material"}.

In situ hybridization {#s4-5}
---------------------

PARAFFIN: After o/n fixation in 4% PFA, hearts were washed in PBS twice, dehydrated in EtOH, and embedded in paraffin. Serial sections were made at 10 µm. In situ hybridization was performed on paraffin-sections as previously described ([@bib45]) except that the hybridization buffer used did not contain heparin and yeast total RNA.

CRYOSECTIONS: Sections were obtained as described earlier. In situ hybridization was performed as for paraffin, however sections were pre-fixed for 10 min in 4% PFA + 0.25% glutaraldehyde before Proteinase K treatment. Moreover, slides were fixed for 1 hr in 4% PFA directly after staining. When in situ hybridization was combined with immunofluorescence, Fast Red staining solution was used instead of NBT-BCIP.

Isolation of single cells from cryoinjured hearts {#s4-6}
-------------------------------------------------

Cryoinjured hearts (n = 13) were extracted at seven dpi. Cells were dissociated according to [@bib67]. For cell sorting, viable cells were gated by negative DAPI staining and positive YFP-fluorescence. In brief, the FACS gating was adjusted to sort cells for nppa:mCitrine^high^ (to enrich for proliferating cardiomyocytes) and nppa:mCitrine^low^ (remote cardiomyocytes and other cell types) cells. In total n = 576 mCitrine^high^ and n = 192 mCitrine^low^ cells were sorted into 384-well plates and processed for mRNA sequencing as described below.

Isolation of single cells from embryonic zebrafish {#s4-7}
--------------------------------------------------

Transgenic *tg(myl7:GFP)* 2-day-old embryos (n = 200) were dechorionated and digested in HBSS Ca^2+^/Mg^2+^ free media containing 0.1% collagenase type II (Gibco) at 32°C for 30--40 min followed by 1X TrypLE Express (Gibco) for 15--30 min at 32°C with agitation. Dissociated cells were then FACSorted and subjected to single-cell mRNA-seq.

Single-cell mRNA sequencing {#s4-8}
---------------------------

Single-cell sequencing libraries were prepared using SORT-seq ([@bib46]). Live cells were sorted into 384-well plates with Vapor-Lock oil containing a droplet with barcoded primers, spike-in RNA and dNTPs, followed by heat-induced cell lysis and cDNA syntheses using a robotic liquid handler. Primers consisted of a 24 bp polyT stretch, a 4 bp random molecular barcode (UMI), a cell-specific 8 bp barcode, the 5' Illumina TruSeq small RNA kit adapter and a T7 promoter. After cell-lysis for 5 min at 65 °C, RT and second strand mixes were distributed with the Nanodrop II liquid handling platform (Inovadyne). After pooling all cells in one library, the aqueous phase was separated from the oil phase, followed by IVT transcription. The CEL-Seq2 protocol was used for library prep ([@bib24]). Illumina sequencing libraries were prepared with the TruSeq small RNA primers (Illumina) and paired-end sequenced at 75 bp read length on the Illumina NextSeq platform. Mapping was performed against the zebrafish reference assembly version 9 (Zv9).

Bioinformatic analysis {#s4-9}
----------------------

To analyze the single-cell RNA-seq data, we used the previously published RaceID algorithm ([@bib21]). For the adult hearts we had a dataset consisting of two different libraries of 384 cells each for a combined dataset of 768 cells, in which we detected 19257 genes. We detected an average of 10,443 reads per cell. Based on the distribution of the log10 total reads plotted against the frequency, we introduced a cutoff at minimally 3500 reads per cell before further analysis. This reduced the number of cells used in the analysis to 352. Next, we downsampled reads to 3500 unique (UMI corrected) transcripts per cell, as means of normalization. Moreover, we discarded genes that were not detected at \>3 transcripts in \>1 cell and These cutoffs is a stringent normalization method that allows us to directly compare detected transcripts between cells from different cell types and libraries. Batch-effects were analyzed and showed no plate-specific clustering of certain clusters.

For embryonic cardiomyocytes, two libraries of 384 cells were combined to obtain a set of 768 cells, in which 22271 genes could be detected. An average of 4412 reads per cell was detected. After downsampling of this library to 3500 reads per cell 302 cells were included for further analysis. Further analysis was performed by combining the embryonic heart data with the injured adult heart data.

The StemID algorithm were used as previously published ([@bib22]). In short, StemID is an approach developed for inferring the existence of stem cell populations from single-cell transcriptomics data. StemID calculates all pairwise cell-to-cell distances (1 -- Pearson correlation) and uses this to cluster similar cells into clusters that correspond to the cell types present in the tissue. The StemID algorithm calculates the number of links between clusters. This is based on the assumption that cell types with less links are more canalized while cell types with a higher number of links have a higher diversity of cell fates. Besides the number of links, the StemID algorithm also calculates the change in transcriptome entropy. Differentiated cells usually express a small number of genes at high levels in order to perform cell specific functions, which is reflected by a low entropy. Stem cells and progenitor cells display a more diverse transcriptome reflected by high entropy ([@bib1]). By calculating the number of links of one cluster to other clusters and multiplying this with the change in entropy, it generates a StemID score, which is representative to 'stemness' of a cell population.

Differential gene expression analysis was performed using the 'diffexpnb', which makes use of the DESeq algorithm. P-values were Benjamini-Hochberg corrected for false discovery rate to make the cutoff.

For the comparison between the embryonic and adult cardiomyocyte clusters, the number of differentially expressed genes between two clusters was calculated as described above and this was used as a measure of similarity between clusters.

Inference of co-expressed gene modules {#s4-10}
--------------------------------------

To identify modules of co-expressed genes along a specific differentiation trajectory (defined as a succession of significant links between clusters as identified by StemID) all cells assigned to these links were assembled in pseudo-temporal order based on their projection coordinate. Next, all genes that are not present with at least two transcripts in at least a single cell are discarded from the sub-sequent analysis. Subsequently, a local regression of the z-transformed expression profile for each gene is computed along the differentiation trajectory. These pseudo-temporal gene expression profiles are topologically ordered by computing a one-dimensional self-organizing map (SOM) with 1000 nodes. Due to the large number of nodes relative to the number of clustered profiles, similar profiles are assigned to the same node. Only nodes with more than three assigned profiles are retained for visualization of co-expressed gene modules. Neighboring nodes with average profiles exhibiting a Pearson's correlation coefficient \>0.9 are merged to common gene expression modules. These modules are depicted in the final map. Analyses were performed as previously published ([@bib22]).

Accession numbers mRNA-seq data are deposited on Gene Expression Omnibus, accession number GSE139218. Samples FK1 and FK2 represent adult cardiomyocytes. Samples LG-A and LG-B represent embryonic cardiomyocytes.

Transmission Electron Microscopy {#s4-11}
--------------------------------

Hearts were excised and immediately chemically fixated at room temperature with 2,5% glutaraldehyde and 2% formaldehyde (EMS, Hainfield USA) in 0.1M phosphate buffer pH 7.4 for 2 hr. Next, hearts were post fixed with 1% OsO~4~ (EMS, Hainfield USA)/1.5% K~3~Fe(CN)~6~ in 0.065 M phosphate buffer for 2 hr at 4°C and finally 1 hr with 0,5% uranyl acetate. After fixation, hearts were dehydrated in a graded series of acetone and embedded in Epon epoxy resin (Polysciences). Ultrathin sections of 60 nm were cut on a Leica Ultracut T (Leica, Vienna, Austria) and contrasted with uranyl acetate (0.4% in AD, EMS, Hainfield USA) and lead citrate (Leica Vienna, Austria) using the AC20 (Leica Vienna, Austria) and examined with a Jeol 1010 electron microscope (Jeol Europe, Nieuw Vennep, The Netherlands).

Quantification of mitochondrial parameters {#s4-12}
------------------------------------------

In every heart, each in the borderzone and remote myocardial region, 100 well-deliniated mitochondria with clearly visible outer and inner membranes were selected. Mitochondrial perimeter and surface were measured using the freehand tool of Image J. The perimeter to surface ratio was calculated and used as a factor that describes the pluriformity of mitochondria. The amount of cristae was estimated by counting the number of cristae intersected by a line of 0.5 µm length in 40 mitochondria per region.

Histology and enzyme histochemistry {#s4-13}
-----------------------------------

Serial cryosections of the heart were cut 7 µm thick and either fixed in formalin, stained with Meyer's hematoxylin and eosin (HE), dehydrated and mounted in Entellan, or incubated for enzyme histochemistry. Chemicals for histochemistry of succinate dehydrogenase (SDH) activity were obtained from Sigma Aldrich. Sections for SDH activity were incubated for 20 min at 28°C in 37.5 mM sodium phosphate buffer pH 7.60, 70 mM sodium succinate, 5 mM sodium azide and 0.4 mM tetranitro blue tetrazolium (TNBT). The reaction was stopped in 10 mM HCl. Controls without succinate did not stain. The incubated sections were mounted in glycerine gelatin. The absorbances of the SDH-reaction product in the sections were determined at 660 nm using a calibrated microdensitometer and ImageJ.

Pharmacological inhibition of glycolysis {#s4-14}
----------------------------------------

ZEBRAFISH: Zebrafish were injured and received intraperitoneal (i.p.) injections twice daily with either PBS or 2-Deoxy-D-Glucose (Sigma-Aldrich, 1 mg/g) from days 3 to 6 and one more injection on day seven after injury, two hours before fish were euthanized and hearts harvested. I.p. injections were performed using a Hamilton Syringe (gauge 30) as described in literature ([@bib34]). Injection volumes were corrected to body weight (30 μl/g).

MAMMALIAN P7 CARDIAC CULTURES: Primary cardiac cultures were isolated from P7 mice using a neonatal dissociation kit (Miltenyi Biotec,130-098-373) using the gentleMACS homogenizer, according to the manufacturer's instructions and cultured in Gelatin-coated (0.1%, G1393, Sigma) wells with DMEM/F12 medium supplemented with L-glutamine, Na-pyruvate, nonessential amino acids, penicillin, streptomycin, 5% horse serum and 10% FBS ('complete-medium') at 37◦C and 5% CO2 for 24 hr. Afterwards, medium was replaced with FBS-depleted medium (otherwise same composition) for additional 48 hr of culture in either 3 mM 2DG (Sigma-Aldrich) or 80 μM lonidamine (Sigma-Aldrich) before further processing.

Ex vivo glucose uptake {#s4-15}
----------------------

Fish were euthanized on ice water before hearts were extracted in PBS + heparin and were allowed to bleed out for 15 min. Hearts were then transferred into fresh PBS + 10%KCl to stop the heart from beating and mounted directly on a glass bottom cell culture dish in 1% agarose. Thereafter, 2NBDG (Caymanchem \#11046, 400 μM) was added to the dish and the hearts were taken directly for imaging. Imaging was performed using a Leica SP5 multiphoton microscopy using 930 nm laser excitation wavelength. 150 μm z-stacks were made with z-step size 5 μm every 5 min for 2 hr.

Gene set enrichment analysis (GSEA) {#s4-16}
-----------------------------------

GSEA (Genepattern, Broad Institute) was performed to assess enrichment for glycolytic genes upregulated between cluster 7 and 2. A list of genes involved in zebrafish glycolysis was obtained from KEGG. As number of permutations 1000 was used, which means p=0 indicates p\<0.001.

Statistical analysis of data {#s4-17}
----------------------------

All statistical testing was performed by unpaired T-tests besides zebrafish qPCR data for which a one-way ANOVA was performed.
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In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.

**Acceptance summary:**

This is a strong and well-written paper with fascinating observations on the roles of the glycolytic pathway in regenerating hearts, Erbb2 upregulation, glycolytic pathway upregulation and cardiomyocyte proliferation. The results indicate that ErbB2 signaling in cardiomyoctes drives a switch from OXPHOS to glycolytic metabolism, resulting in reentry into the cell cycle during the regeneration response.

**Decision letter after peer review:**

Thank you for submitting your article \"Single-cell analysis uncovers metabolic reprogramming in proliferating cardiomyocytes of the regenerating heart\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by Marianne Bronner as the Senior and Reviewing Editor. The following individual involved in review of your submission has agreed to reveal their identity: Shawn Burgess (Reviewer \#1).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

This paper leads with very useful single cell transcriptome analysis of adult zebrafish hearts in response to injury, compared to developing hearts in zebrafish embryos, with a general theme that regeneration response reprograms cells toward dedifferentiation and proliferation. The combination of a transgenic line that labels cardiomyocytes at the \'border zone\' near the injury site and ssRNA-seq reveals important local changes in metabolic genes, and metabolic activity, in response to cardiac injury, correlated with increases in proliferation. This concurs with an interesting change in mitochondria morphology. From these results, the focus is turned to the roles of the glycolytic pathway in regenerating hearts, and pathway of Erbb2 upregulation, glycolytic pathway upregulation and cardiomyocyte proliferation. The results indicate that ErbB2 signaling in cardiomyoctes drives a switch from OXPHOS to glycolytic metabolism, resulting in rentry into the cell cycle. Overexpression of ErbB2 in mice hearts gives a similar switch in metabolic pathway gene expression. Inhibition of glycolysis by 2-Deoxy glucose (2DG) treatments reduces the proportion of PCNA-labeled cardiomyocytes.

Essential revisions:

The full reviews below provide some guidance about revisions that are textual or require checks of statistical analysis and cut-off parameters.

Reviewer \#1:

Honkoop and colleagues have submitted a manuscript describing the isolation and scRNA-seq experiments performed on regenerating adult zebrafish hearts. Specifically they used a *nppa*:mCitrine transgenic reporter to FAC sort cells from the \"border zone\" of the regenerating heart. Bioinformatic analysis demonstrated a de-differentiation of the cardiomyocytes towards a more embryonic-like gene state and that this transition was triggered by ErbB2 signaling. They also showed an obligate metabolic shift from aerobic to anaerobic respiration triggered by the ErbB2 signals and that regeneration was significantly inhibited if glycolysis was blocked by 2DG. Despite a more limited ability to regenerate in mice, they were able to also show similar effects in mouse cardiomyocytes, particularly in a transgenic model expressing constitutively active form of ErbB2. These results are interesting, well controlled and of general interest to the readers of *eLife*.

Reviewer \#2:

1\) The authors are commendably careful in their title, summary and discussion of the results with respect to cardiac regeneration. They have not shown that inhibition of the glycolytic pathway alters the ability of the zebrafish heart to regenerate, only that it reduces reentry into the cell cycle, which of course is a step used in regeneration. The single cell transcriptome analysis and most of the gene expression analysis was done at 7 days post injury (dpi), which is appropriate to capture the early steps in the process, during the cardiomyocyte responses to heart injury. In contrast, to test the effects of functional alteration of metabolic pathways on regeneration per se, the hearts would have to be analyzed later in the process, around 30 days post injury, which has not been provided. In keeping with this, one sentence at the end of the summary \"Together these results reveal a new mechanism in which glycolysis regulates cardiomyocyte proliferation and heart regeneration\" should be changed to \"during heart regeneration.\"

2\) In Figure 6, the Nrg1 OE hearts look quite different morphologically from the control hearts. Please discuss what is happening; is the overexpression significantly altering the heart function/physiology? It is also interesting that Nrg1/caErbB2 in fish/mice hearts appears to induce overexpression of glycolytic genes in some parts of the heart, but not others, perhaps compact outer myocardium in fish and inner myocardium in mice. Is this observation consistent? If so, worth a brief mention.

3\) In Figure 6, it appears that in the PCR analysis, HK1 increased expression in response to injury (as seen in situ, Figure 4) and in Nrg1 OE hearts, but does not appear to be decreased by inhibition of Erbb2. This is worth a brief comment.

4\) In Figure 5, it would be useful to see a larger view of the hearts, not just the zoomed in region of the border zone.

Reviewer \#3:

Here, Honkoop et al. generated a transgenic line that labels proliferating cardiomyocytes at the wound border zone. Using this line, the authors isolate border zone cardiomyocytes using SORT-seq and find that border zone cardiomyocytes have a distinct transcriptional profile that resembles embryonic cardiomyocytes. In this regard, the border zone cardiomyocytes have an upregulation of glycolysis gene expression suggesting a metabolic reprogramming is required for proliferation of cardiomyocytes at the onset of injury. Furthermore, the authors describe a mechanism underlying metabolic reprogramming by induction of Nrg1/ErbB2 signaling. Overall, the authors contribute to our understanding of how regeneration reactivates developmental programs by activating a transcriptional profile similar to embryonic populations including metabolic reprogramming to a more embryonic mechanism.

1\) The authors analyzed 352 cells after a cutoff of a minimum of 3500 reads per cells. This seems a bit high of a cutoff, and with such stringency, they could be missing heterogeneity within cardiomyocytes populations by analyzing roughly half of the cells originally collected. Could the authors comment on why they decided on such a high reads per cell cutoff?

2\) A GO analysis of the different single cell clusters would highlight the similarities and differences between clusters. It would be particularly interesting to see GO term analyses when comparing the embryonic and proliferating cardiomyocyte cluster.

3\) Pseudotime analysis suggested that glycolysis gene induction preceded embryonic gene expression. Is this known to be the same order of events in the developing heart?

10.7554/eLife.50163.sa2

Author response

> Essential revisions:
>
> Reviewer \#2:
>
> 1\) The authors are commendably careful in their title, summary and discussion of the results with respect to cardiac regeneration. They have not shown that inhibition of the glycolytic pathway alters the ability of the zebrafish heart to regenerate, only that it reduces reentry into the cell cycle, which of course is a step used in regeneration. The single cell transcriptome analysis and most of the gene expression analysis was done at 7 days post injury (dpi), which is appropriate to capture the early steps in the process, during the cardiomyocyte responses to heart injury. In contrast, to test the effects of functional alteration of metabolic pathways on regeneration per se, the hearts would have to be analyzed later in the process, around 30 days post injury, which has not been provided. In keeping with this, one sentence at the end of the summary \"Together these results reveal a new mechanism in which glycolysis regulates cardiomyocyte proliferation and heart regeneration\" should be changed to \"during heart regeneration.\"

We agree that the research performed in this manuscript is limited to the cardiomyocyte proliferation aspect of zebrafish heart regeneration and have changed the sentence at the end of the summary as suggested.

> 2\) In Figure 6, the Nrg1 OE hearts look quite different morphologically from the control hearts. Please discuss what is happening; is the overexpression significantly altering the heart function/physiology?

As a response to the Nrg1 overexpression, the cardiomyocytes in the cortical layer will disassemble sarcomere structures and initiate cell proliferation, resulting in a thickening of mainly the cortical layer, which has been described in Gemberling et al., 2015. The overexpression of *nrg1* leads to a specific and consistent thickening of the ventricular wall already at 14dpt. Further analysis on the model revealed this thickening was accomplished by an increase in cardiomyocyte number rather than hypertrophy of existing cardiomyocytes. At first, physiology in *nrg1* OE fish is unaffected, but after three months it appears cardiac function improves as a result of the overexpression as atrioventricular filling improves. This beneficial effect turns into a negative effect after 8 months of overexpression, due to deleterious growth.

> It is also interesting that Nrg1/caErbB2 in fish/mice hearts appears to induce overexpression of glycolytic genes in some parts of the heart, but not others, perhaps compact outer myocardium in fish and inner myocardium in mice. Is this observation consistent? If so, worth a brief mention.

The localization of glycolysis markers is consistent between biological repeats, in both the zebrafish and mouse hearts.

In the zebrafish the tested glycolysis markers show the strongest signal in the cortical layer coinciding with high proliferation in this region. It is still unknown why the effect of *nrg1* OE in this model leads to a more pronounced effect in the cortical myocardium compared to the trabecular myocardium.

We have made some textual changes to clarify the effect of *nrg1* OE in the zebrafish heart: "In this model especially cortical cardiomyocytes start to divide after tamoxifen injection leading to thickening of this layer. We observed a profound and consistent upregulation of glycolysis genes in the cortical myocardium coinciding with the reported cardiomyocyte dedifferentiation and proliferation in this layer (Figure 6A)."

In the caErbB2 OE mouse model we observed consistent pPDH signal in the inner myocardial layer, which we now mention in the subsection "Activating ErbB2 signaling induces a metabolic switch from OXPHOS to glycolysis and lactate fermentation in murine cardiomyocytes". We don't have a good explanation for the stronger pPDH staining in the inner layer compared to the outer layer. In the caErbB2 OE model cardiomyocyte proliferation occurs throughout the myocardium.

> 3\) In Figure 6, it appears that in the PCR analysis, HK1 increased expression in response to injury (as seen in situ, Figure 4) and in Nrg1 OE hearts, but does not appear to be decreased by inhibition of Erbb2. This is worth a brief comment.

The reviewer rightly points to the fact that *hk1* is not downregulated in the border zone after ErbB2 inhibition. On the contrary, we have shown that Nrg1 is indeed able to upregulate *hk1* expression in the Nrg1 OE model. This discrepancy can most likely be explained by redundant upstream factors accounting for border zone *hk1* expression in the absence of Nrg1/ErbB2 signaling. We have added a brief comment on this in the revised manuscript: "In contrast to the other glycolysis genes, *hk1* expression was not reduced after AG1478 treatment likely as a result of redundant signaling pathways in the borderzone.".

> 4\) In Figure 5, it would be useful to see a larger view of the hearts, not just the zoomed in region of the border zone.

A larger view of the hearts treated either with PBS or 2DG has been added to Figure 5 to give a better overview of the hearts 7 days post injury.

> Reviewer \#3:
>
> \[...\] 1) The authors analyzed 352 cells after a cutoff of a minimum of 3500 reads per cells. This seems a bit high of a cutoff, and with such stringency, they could be missing heterogeneity within cardiomyocytes populations by analyzing roughly half of the cells originally collected. Could the authors comment on why they decided on such a high reads per cell cutoff?

Here, the reviewer raises a valid question on how we determined the read cutoff for our single cell sequencing analysis. We had a dataset consisting of two different libraries of 384 cells each for a combined dataset of 768 cells. In the combined library we detected an average of 10,443 reads per cell. Based on the distribution of the log10 total reads plotted against the frequency, we decided to introduce a cutoff at minimally 3500 reads per cell before further analysis (see diagnostic graph in [Author response image 1A](#respfig1){ref-type="fig"}). This reduced the number of cells to 352. Cutoffs depend on cell type and hence can vary between different organs with different cell type composition. Importantly, lowering the cutoff to a lower number of reads will result in more included cells but will result in the loss of information on lowly expressed transcript as a result of down sampling of the data to the read cutoff. In this process reads in a cell are lost in order to make cells with different read counts comparable. With the chosen cutoff we lost the minimum of rare transcript information while including enough cells to not miss any heterogeneity within the cardiomyocyte population.

In order to justify the choice of thresholds for filtering we performed the analysis at both lower and higher cutoffs. These analyses show that while the amount of included cells is influenced by different cutoffs, the clustering pattern is retained ([Author response image 1B](#respfig1){ref-type="fig"}). This is also recapitulated by the expression of two example genes *nppa* and *ttna*, both highly expressed in the cells which are referred to as cluster 7 in the original manuscript ([Author response image 1C](#respfig1){ref-type="fig"}). Note that the number of clusters decreases when a lower read cutoff is used as a result of down sampling (n=5 for cutoff of 500, n=12 for cutoff of 3500), leading to the loss of valuable information.

![Different read cut-offs do not alter clustering pattern, while altering number of included cells.\
(**A**) Distribution of reads per cell. Green line represents 3,500 reads, red line indicates the mean number of reads per cell (10,443). (**B**) tSNE maps generated with different read cutoffs. Read cutoffs and included number of cells are indicated on top of tSNE maps. (**C**) Expression of two marker genes of dedifferentiated cardiomyocytes: *nppa* and *ttna*.](elife-50163-resp-fig1){#respfig1}

> 2\) A GO analysis of the different single cell clusters would highlight the similarities and differences between clusters. It would be particularly interesting to see GO term analyses when comparing the embryonic and proliferating cardiomyocyte cluster.

We agree that performing GO term analysis on our single cell data could give valuable insights into processes that differ between the clusters. To gain more insight into this DAVID functional annotation was used to get info on these mechanisms.

First, we performed GO term analysis on adult cardiomyocytes only. Here we compared the dedifferentiated cardiomyocytes from cluster 7 to the more mature cardiomyocytes in cluster 2 ([Author response image 2](#respfig2){ref-type="fig"}). As expected from pseudo time analysis we found multiple GO terms related to metabolism differentially regulated between clusters. Moreover, translation and sarcomere related GO-terms were upregulated in cluster 7.

Next, we compared the proliferating adult cardiomyocyte cluster 5 from our combined analysis to embryonic cardiomyocyte cluster 6. This analysis suggests that proliferating adult cardiomyocytes are highly active in sarcomere assembly and have more oxidative capacity than embryonic cardiomyocytes (or are in the process of establishing this). Embryonic cardiomyocytes on the other hand expressed genes involved in heart development, production of extracellular matrix and developmental pathways such as Wnt and Tgf-b.

We have added a complete list of GO-terms for the comparison of proliferating (cluster 7) and non-proliferating (cluster 2) adult cardiomyocytes to Figure 1---source data 3 as well as a smaller list of GO-terms to Figure 4---figure supplement 1. Moreover, we have added the complete lists of GO-terms comparing all embryonic and adult cardiomyocyte clusters from our combined analysis to Figure 2---source data 4.

![GO-term analysis on differentially expressed genes in cardiomyocyte clusters.\
Representative GO-terms for cardiomyocyte clusters. GO-terms in upper table are obtained from differentially expressed genes between adult clusters 2 and 7 (p\<0.01). Lower table GO-terms are obtained from differentially expressed genes between cluster 5 (Proliferating adult CM) and cluster 6 (Embryonic CM) of the combined single-cell analysis.](elife-50163-resp-fig2){#respfig2}

> 3\) Pseudotime analysis suggested that glycolysis gene induction preceded embryonic gene expression. Is this known to be the same order of events in the developing heart?

This is an interesting question. Glycolysis genes such as *eno1a, hk1* and *ldha* are already well expressed in the gastrulating (shield stage) embryo (based on tomo-seq data: http://zebrafish.genomes.nl). In addition, we have performed in situhybridizations for these glycolytic genes in later stages of the developing embryo and observed high expression in the developing embryo including the heart ([Author response image 3](#respfig3){ref-type="fig"}). Interestingly, glycolysis genes are highly expressed in the developing heart at 28 and 48 hpf, but much lower at later stages of development (5dpf). This observation suggests that there is an inverse correlation of glycolytic gene expression and the maturation state of cardiomyocytes, which is in good agreement with data from other animal models.

![Glycolytic gene expression in the embryonic zebrafish heart.\
Expression of *eno1a* (**a, b, c, d**), *hk1* (**e, f, g, h**) and *ldha* (**i, j, k, l**) during zebrafish development at 28hpf (**a, e, i**), 48 hpf (**b, f, j**) and 5dpf (**c, d, g, h, k, l**) respectively. Outline of the heart is indicated by dashed lines.](elife-50163-resp-fig3){#respfig3}

[^1]: These authors contributed equally to this work.
